Superior sagittal sinus thrombosis as a focal point of pulmonary embolism

This article represents the discussion of a clinical case of superior sagittal sinus thrombosis as a focal point of fatal pulmonary embolism. Pulmonary embolism is a life-threatening condition, with a mortality rate of up to 40%. The direct source of pulmonary embolism is deep vein thrombosis of the lower extremities and pelvis in 80–90% of all cases. The veins of the upper extremities and venous heart cause it less often. Pulmonary embolism in patients with cerebral venous thrombosis is observed in 1.4% of patients.
Cerebral venous thrombosis is a cerebrovascular disease manifested by venous outflow disorders due to acute occlusion of the sinuses and veins of the brain. It requires immediate treatment in order to prevent the development of intracranial hemorrhage, venous infarction, disability and death. Cerebral venous thrombosis accounts for approximately 0.5% of all cases of cerebrovascular disease worldwide. In contrast to ischemic stroke, cerebral venous thrombosis is more common in younger patients. Currently, the diagnosis of cerebral venous thrombosis is based on neuroimaging data, and timely treatment leads to a decrease in disability and mortality.

1. Liberman A.L., Merkler A.E., Gialdini G., Messé S.R., Lerario M.P., Murthy S.B. et al. Risk of Pulmonary Embolism after Cerebral Venous Thrombosis. Stroke. 2017;48(3):563–567. https://doi.org/10.1161/STROKEAHA.116.016316

2. Bergquist D., Lindblad В. Incidence of venous throm-boembolism in medical and surgical patients. In: Bergquist D., Comerota A.G., Nicolaides A.N. et al. (eds.) Prevention of venous thromboembolism. London; Los Angeles; Nicosia: Med Orion Publishing Company; 1994:3–16.

3. Diaz J.M., Schiffman J.S., Urban E.S., Maccario M. Superior sagittal sinus thrombosis and pulmonary embolism: a syndrome rediscovered. Acta Neurol. Scand. 1992;86(4):390–396. https://doi.org/10.1111/j.1600-0404.1992.tb05106.x

4. Stam J. Thrombosis of the cerebral veins and sinuses. N. Engl. J. Med. 2005;28;352(17):1791–1798. https://doi.org/10.1056/NEJMra042354

5. Krayenbuhl H.A. Cerebral venous and sinus thrombosis. Neurol. Med. Chir. (Tokyo). 1968; 10:1–24. https://doi.org/10.2176/nmc.10.1

6. Ferro J.M., Canhao P., Stam J., Bousser M.-G., Barinagarrementeria F., ISCVT Investigators. Prognosis of cerebral vein and dural sinus thrombosis: results of the International Study on Cerebral Vein and Dural Sinus Thrombosis (ISCVT). Stroke. 2004;35(3):664–670. https://doi.org/10.1161/01.STR.0000117571.76197.26

7. Bousser M.G., Ferro J.M. Cerebral venous thrombosis: an update. Lancet Neurol. 2007;6(2):162–170. https://doi.org/10.1016/S1474-4422(07)70029-7

8. Paciaroni M., Palmerini F., Bogousslavsky J. Clinical presentations of cerebral vein and sinus thrombosis. Front Neurol. Neurosci. 2008;23:77–88. https://doi.org/10.1159/000111262

9. Wasay M., Bakshi R., Bobustuc G., Kojan S., Sheikh Z., Dai A. et al. Cerebral venous thrombosis: analysis of a multicenter cohort from the United States. J. Stroke Cerebrovasc. Dis. 2008;17(2):49–54. https://doi.org/10.1016/j.jstrokecerebrovasdis.2007.10.001

10. Bontadel li J., Müntener D., Hungerbühler H. Cerebral venous sinus thrombosis and pulmonary embolism: Cause or coincidence? Clin. Neurophys. 2012;123(10):e108. https://doi.org/10.1016/j.clinph.2012.03.064

11. Saposnik G., Barinagarrement eria F., Brown R.D. Jr., Bushnell C.D., Cucchiara B., Cushman M. et al. Diagnosis and management of cerebral venous thrombosis: a statement for healthcare professionals from the American Heart Association/American Stroke Association. Stroke. 2011;42(4):1158–1192. https://doi.org/10.1161/STR.0b013e31820a8364

12. Ferro J.M., Bousserc M.G., Canhao P., Coutinhod J.M., Crassardc I., Dentalie F. et al. European Stroke Organization guideline for the diagnosis and treatment of cerebral venous thrombosis – endorsed by the European Academy of Neurology. Eu.r J. Neurol. 2017;24(10):1203–1213. https://doi.org/10.1111/ene.13381

13. Masuhr F., Busc h M., Amberger N., Ortwein H., Weih M., Neumann K. et al. Risk and predictors of early epileptic seizures in acute cerebral venous and sinus thrombosis. Eur. J. Neurol. 2006;13(8):852–856. https://doi.org/10.1111/j.1468-1331.2006.01371.x

14. Mahale R., Mehta A., John A.A., Buddaraju K., Shankar A.K., Javali M. et al. Acute seizures in cerebral venous sinus thrombosis: what predicts it? Epilepsy Res. 2016;123:1–5. https://doi.org/10.1016/j.eplepsyres.2016.01.011

15. PREPIC Study Group. Eight-year follow-up of patients with permanent vena cava filters in the prevention ofpulmonary embolism: the PREPIC (Prevention du Risque d’Embolie Pulmonairepar Interruption Cave) randomized study. Circulation. 2005;112(3):416–422. https://doi.org/10.1161/CIRCULATIONAHA.104.512834

16. Usoh F ., Hingorani A., Ascher E., Shiferson A., Tran V., Marks N. et al. Long-term follow-up for superior vena cava filter placement. Ann. Vasc. Surg. 2009;23(3):350–354. https://doi.org/10.1016/j.avsg.2008.08.012

17. Uzar E., Ekici F., Acar A., Yucel Y., Bakir S., Tekb as G. et al. Cerebral venous sinus thrombosis: an analysis of 47 patients. Eur. Rev. Med. Pharmacol. Sci. 2012;16(11):1499–1505. PMID: 23111961